Published in Anticancer Res on August 05, 2005
Targeted drug delivery for cancer therapy: the other side of antibodies. J Hematol Oncol (2012) 1.21
A humanized monoclonal antibody specific for invariant Natural Killer T (iNKT) cells for in vivo depletion. PLoS One (2013) 0.90
Bevacizumab for the treatment of glioblastoma. Clin Med Insights Oncol (2013) 0.90
Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma. Cancer Gene Ther (2014) 0.78
Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis. Antimicrob Agents Chemother (2006) 0.77
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia. J Clin Pharmacol (2015) 0.76
Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization. Biomed Res Int (2015) 0.75
Influence of Escherichia coli chaperone DnaK on protein immunogenicity. Immunology (2016) 0.75
Population Pharmacokinetic Meta-Analysis of Ramucirumab in Cancer Patients. Br J Clin Pharmacol (2017) 0.75
Macrophage activity in infected areas of an experimental vertebral osteomyelitis model: USPIO-enhanced MR imaging--feasibility study. Radiology (2008) 1.67
Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation. Eur Radiol (2009) 1.58
Septic arthritis: monitoring with USPIO-enhanced macrophage MR imaging. Radiology (2011) 1.57
Clinical pharmacokinetics of voriconazole. Int J Antimicrob Agents (2006) 1.10
MRI of macrophages in infectious knee synovitis. AJR Am J Roentgenol (2010) 0.90
Percutaneous inoculated rabbit model of intervertebral disc space infection: magnetic resonance imaging features with pathological correlation. Joint Bone Spine (2008) 0.88
Cellular magnetic resonance imaging for the differentiation of infectious and degenerative vertebral disorders: preliminary results. J Magn Reson Imaging (2009) 0.86
Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrob Agents Chemother (2003) 0.83
Molecular pharmacokinetics of catharanthus (vinca) alkaloids. J Clin Pharmacol (2007) 0.81
Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation. Crit Care (2006) 0.81
Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics. Antimicrob Agents Chemother (2012) 0.81
Ocular penetration of topically applied linezolid in a rabbit model. J Cataract Refract Surg (2010) 0.80
Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases. PLoS One (2013) 0.79
Ex vivo pharmacodynamics of amoxicillin-clavulanate against beta-lactamase-producing Escherichia coli in a yucatan miniature pig model that mimics human pharmacokinetics. Antimicrob Agents Chemother (2002) 0.79
Determination of fosmidomycin in human serum and urine by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.78
Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults. Antimicrob Agents Chemother (2004) 0.78
Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis. Invest Ophthalmol Vis Sci (2012) 0.78
In vitro activity of daptomycin against Enterococcus faecalis under various conditions of growth-phases, inoculum and pH. PLoS One (2013) 0.76
In vivo macrophage imaging using MR targeted contrast agent for longitudinal evaluation of septic arthritis. J Vis Exp (2013) 0.75
Molecular determinants of fluoroquinolone antibacterial agents pharmacokinetics. Curr Clin Pharmacol (2009) 0.75
The effect of rifampin on the pharmacokinetics of vinorelbine in the micropig. Anticancer Res (2003) 0.75
Ocular penetration of linezolid after oral administration in rabbits. J Ocul Pharmacol Ther (2011) 0.75